Oxford University Press (OUP) is the proud publishing partner of Antibody Therapeutics, the official journal of ChAbS. As a department of the University of Oxford, OUP is a mission‑driven, non‑profit publisher committed to delivering world‑class academic and educational resources and making them widely accessible. Published on Oxford Academic, Antibody Therapeutics is a peer‑reviewed, fully open access journal dedicated to publishing the latest advances and challenges across the discovery, research, development, manufacturing, and methodology of therapeutic antibodies.
 

As the society’s official journal, Antibody Therapeutics provides a trusted platform for original research, reviews, and emerging technologies, connecting academic, industry, and translational communities worldwide. Authors publish with the journal for its rigorous and fair peer review, rapid editorial decision‑making, and global open access visibility. Through its partnership with ChAbS, OUP supports ethical, transparent publishing and helps ensure impactful antibody research reaches a broad international audience.